Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2Planned workforce ...

“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...

Planview continued strong momentum through 2024, marked by customer growth, product innovations and industry recognition.

TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been recognized by CIOTechOutlook as one ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of ...

Robert F. Kennedy Jr. transferred ownership of the trademark application in December and its abbreviation — MAHA — to an LLC ...

It might encompass elements such as headlines, body copy, images, calls-to-action, legal copy and logos ... on opening up and having pharma’s internal teams working together to speed up the ...

The "Pharmaceutical Regulatory Affairs in Asia Training Course" has been added to ResearchAndMarkets.com's offering. The pharmaceutical market in Asia is growing at a rapid pace and presents both ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET Orion and Invenra announce discovery service and commercial ...

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.